In vivo studies demonstrated that FeSR780@CAT@Mex-RS17 NPs exhibited low systemic toxicity in a lung cancer mouse model, induced DC maturation, and enhanced tumor infiltration by CD8+ T cells, resulting in a better antitumor effect. This evidence concerns the gene CD8A and lung carcinoma.